focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,471.00
Bid: 1,450.00
Ask: 1,520.00
Change: 0.00 (0.00%)
Spread: 70.00 (4.828%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,471.00
SMSN Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sales of Stakes-Replacement

6 Nov 2015 09:02

RNS Number : 8287E
Samsung Electronics Co. Ld
06 November 2015
 



The following amendments have been made to the ' Sales of Stakes' announcement released on Oct 30, 2015 at 07:00 under RNS No. 9690D.

Original

Amendment

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") announced today on Oct 30, 2015 has authorized the sales of SEC's stake in Samsung Fine Chemicals Co., LTD. to Lotte Chemical Corporation.

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC" or the "Company") announced on October 30, 2015 that the Company has authorized the sale of its entire stake in Samsung Fine Chemicals Co., LTD. to Lotte Chemical Corporation.

1. Details of Transaction:

Samsung Electronics plans to sell a total of 2,164,970 shares of Samsung Fine Chemicals, as well as stakes in other affiliates(Samsung SDI, Samsung C&T, Hotel Shilla, and Samsung Electro-Mechanics).

1. Details of Transaction:

The Company plans to sell a total of 2,164,970 shares of Samsung Fine Chemicals. Certain other affiliates of SEC(i.e., Samsung SDI, Samsung C&T, Hotel Shilla, and Samsung Electro-Mechanics) have also announced their plans to sell their respective stakes in Samsung Fine Chemicals.

3. Date of the Definitive Agreement

The effective date of the definitive agreement is 30 October 2015. The asset transfer reflecting adjustments will be completed within the first half of 2016.

3. Date of the Definitive Agreement

The effective date of the definitive agreement is 30 October 2015. The transaction is expected to close within the first half of 2016.

4. Reason for Divestment

The purpose of divestment is to reinvest the capital in new businesses and in SEC's existing to strengthen the company's core competencies.

4. Reason for Divestment

The purpose of the divestment is to secure capital for investment in new businesses as well as allocating additional resources to strengthen the Company's core competencies.

All other details remain unchanged.

The full amended text is shown below.

 

Sales of Stakes-Replacement

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC" or the "Company") announced on October 30, 2015 that the Company has authorized the sale of its entire stake in Samsung Fine Chemicals Co., LTD. to Lotte Chemical Corporation. The transaction is subject to regulatory review and certain other customary closing conditions. SEC expects that the transaction will close within the first half of 2016. Samsung Fine Chemicals is an affiliate of SEC.

 

Details

1. Details of Transaction:

The Company plans to sell a total of 2,164,970 shares of Samsung Fine Chemicals. Certain other affiliates of SEC(i.e., Samsung SDI, Samsung C&T, Hotel Shilla, and Samsung Electro-Mechanics) have also announced their plans to sell their respective stakes in Samsung Fine Chemicals.

* Total number of Samsung Fine Chemicals shares issued: 25,800,000

2. Transaction Amount (Total Consideration): KRW 125.350 billion *

* Subject to adjustments in consideration as per the definitive agreement

3. Date of the Definitive Agreement

The effective date of the definitive agreement is 30 October 2015. The transaction is expected to close within the first half of 2016.

4. Reason for Divestment

The purpose of the divestment is to secure capital for investment in new businesses as well as allocating additional resources to strengthen the Company's core competencies.

 

5. Other Information

ž Details on contract resolution (including put-option): None

 

* This public disclosure is in accordance with the Financial Investment Services and Capital Markets Act (Article 200-1) of the Republic of Korea, which requires major shareholders of a stock-listed corporation to report matters concerning the current status of specific securities, etc. owned by type and changes therein. This disclosure contains forward-looking statements. Readers are cautioned that such forward-looking statements involve risks and uncertainties that could significantly affect actual results from those expressed in any such forward-looking statements due to, without limitation, (i) general economic conditions, including in particular economic conditions in SEC's core businesses and core markets, (ii) performance of financial markets, including emerging markets, and including market volatility, liquidity and credit events, (iii) currency exchange rates, (iv) changing levels of competition, (v) changes in laws and regulations, (vi) general competitive factors, in each case on a local, regional, national and/or global basis. The matters discussed herein may also be affected by risks and uncertainties described from time to time in SEC's filings with the Korea Stock Exchange (KRX), FSS (Korea) and Samsung Website. Further information about risks and uncertainties affecting Samsung Electronics Co., Ltd. is included throughout our most recent annual and interim reports, as well as our most recent earnings release, which are available on http://www.samsung.com/ir. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results, performance or achievements of SEC may vary materially from those described in the relevant forward-looking statement, and all such statements are subject to certain risks and uncertainties that could cause our actual results to be materially different from those expressed herein. The company assumes no obligation to update any forward-looking statement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIBDBUUGBGUL
Date   Source Headline
17th Feb 202210:18 amRNSReference Material for 2022 AGM
17th Feb 20228:40 amRNS2021 Separate Financial Statements
17th Feb 20228:30 amRNS2021 Consolidated Financial Statements
15th Feb 202211:35 amRNSReference Material for 2022 AGM
15th Feb 202211:24 amRNSTransaction with Affiliate Company
15th Feb 202211:21 amRNSAppointment of New Chief Executive Officer
15th Feb 202211:16 amRNSCharitable Contribution
27th Jan 20227:05 amRNSYear-End Dividend for FY2021
27th Jan 20227:00 amRNS2021 4Q Earnings Release
7th Jan 20227:00 amRNSNotice of 4Q 2021 Earnings Release Schedule
7th Jan 20227:00 amRNS4Q 2021 Pre-Earnings Guidance
1st Dec 202110:03 amRNSCharitable Contributions
30th Nov 202112:52 pmRNS2021 3Q Interim Business Report
30th Nov 202111:15 amRNSTransactions with Affiliated Companies
24th Nov 20218:11 amRNSInvestment in Fabrication Plant
10th Nov 20217:55 amRNSAnnouncement of Investor Relations Event
28th Oct 20218:22 amRNSCharitable Contribution
28th Oct 20218:18 amRNSTransaction with Affiliate Company
28th Oct 20218:04 amRNSTransaction with Affiliate Company
28th Oct 20218:03 amRNSQuarterly Dividend for Third Quarter 2021
28th Oct 20217:59 amRNS2021 3Q Earnings Release
8th Oct 20218:05 amRNSNotice of 3Q 2021 Earnings Release Schedule
8th Oct 20218:04 amRNS3Q 2021 Pre-Earnings Guidance
31st Aug 202110:39 amRNS2021 Half-year Business Report
29th Jul 20218:12 amRNSRenewal of Property & Casualty Insurance Policy
29th Jul 20218:07 amRNSQuarterly Dividend for Second Quarter 2021
29th Jul 20218:06 amRNS2021 2Q Earnings Release
7th Jul 20218:25 amRNSNotice of 2Q 2021 Earnings Release Schedule
7th Jul 20218:17 amRNS2Q 2021 Pre-Earnings Guidance
6th Jul 202110:04 amRNSSustainability Report 2021
1st Jun 20217:00 amRNS2021 1Q Interim Report
1st Jun 20217:00 amRNSCorporate Governance Report FY2020
20th May 20219:20 amRNS2020 Separate Financial Statements
12th May 202110:23 amRNS2020 Business Report
30th Apr 202110:28 amRNS2020 Business Report
30th Apr 202110:13 amRNSChange of the Major Shareholder
29th Apr 202110:41 amRNSCharitable Contribution
29th Apr 202110:38 amRNSCharitable Contribution
29th Apr 202110:34 amRNSCharitable Contribution
29th Apr 202110:33 amRNSTransaction with Affiliate Company
29th Apr 202110:26 amRNSQuarterly Dividend for First Quarter 2021
29th Apr 202110:20 amRNS2021 1Q Earnings Release
7th Apr 20219:12 amRNSNotice of 1Q 2021 Earnings Release Schedule
7th Apr 20219:07 amRNS1Q 2021 Pre-Earnings Guidance
17th Mar 20218:39 amRNSTransaction with Affiliate Company
17th Mar 20218:34 amRNSResults of the 52nd Annual General Meeting
18th Feb 20217:34 amRNS2020 Consolidated Financial Statements
16th Feb 202110:13 amRNSReference Material for 2021 AGM
16th Feb 20219:03 amRNSTransaction with an affiliate
16th Feb 20219:02 amRNSTransaction with an affiliate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.